Location: United States
Employees: 51-200
Total raised: $46M
Founded date: 2000
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.06.2026 | Series A | $37M | Lightspeed... |
| 28.09.2010 | - | $9M | - |
Mentions in press and media 11
| Date | Title | Description |
| 19.06.2026 | Andera Raises $37M in Series A Funding | Andera, a San Francisco, California-based developer of an AI-native internal audit and corporate compliance testing platform, raised $37m in Series A funding. The round was led by Lightspeed Venture Partners. The company intends to use the ... |
| 22.01.2026 | Exciva Secures €51 Million Series B: Alzheimer's Agitation Therapy Advances to Phase 2 | Exciva closed a €51 million Series B funding round. This financing fuels Deraphan, its Alzheimer's agitation therapy, into crucial Phase 2 trials. EQT Life Sciences and Gimv spearheaded the investment. The global study addresses a pressing ... |
| 20.01.2026 | EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2 | EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2 Tue, Jan 20, 2026 07:30 CET Report this content Series B financing will support Exciva’s Phase 2 clinical trial of its lea... |
| 03.11.2025 | Tubulis: Second Tranche Of €344 Million Series C Closed To Advance ADC Pipeline | Tubulis announced the second and final closing of its Series C financing round, bringing the total raised to €344 million ($401 million). The round included new investors Fidelity Management & Research Company, Janus Henderson Investors... |
| 15.10.2025 | Tubulis: €308 Million Series C Secured To Advance Clinical Development Of Lead ADC Candidate TUB-040 | Tubulis announced the closing of a €308 million ($361 million) Series C financing round aimed at accelerating the clinical development of its lead antibody-drug conjugate (ADC) candidate, TUB-040. The round was led by Venrock Healthcare Cap... |
| 01.07.2025 | 2024 Sustainability Report | We are pleased to present our latest Sustainability Report, highlighting the progress achieved by Andera Partners and its portfolio companies over the past year: Climate – advancing decarbonizationOur climate strategy, aligned with the Scie... |
| 09.12.2021 | Andera Partners announces 1st closing at €84m for Andera Smart Infra 1 | Andera Partners, a leading private equity player focusing on high-growth SMEs and mid-caps in France and internationally, has completed an initial €84 million fundraising for its Andera Smart Infra 1 fund. This success reflects investors’ s... |
| 02.08.2021 | PRESS RELEASE : Andera Partners' Portfolio Company T-knife Announces USD110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies | DGAP-News: Andera Partners / Key word(s): Financing Andera Partners' Portfolio Company T-knife Announces USD110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies 2021-08-02 / 14:05 The issuer is solely responsible ... |
| 08.05.2014 | Bottomline Technologies Acquires Andera for $44.5M | Andera Inc., a Providence, R.I.-based provider of a Software as a Service solution that simplifies account opening and lending for banks and credit unions, has been acquired by Bottomline Technologies for $44.5m in cash. Bottomline Technolo... |
| 30.09.2010 | Andera Receives $9M Investment from Edison Ventures | Andera, a Providence, R.I.-based provider of online customer acquisition solutions to financial institutions, received a $9m investment from Edison Ventures. The capital will be used to grow sales, marketing, and product development. Andera... |
Show more